Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD (RRFT)
|ClinicalTrials.gov Identifier: NCT01751035|
Recruitment Status : Active, not recruiting
First Posted : December 17, 2012
Last Update Posted : January 11, 2018
|Condition or disease||Intervention/treatment||Phase|
|PTSD Alcohol Use Disorders Substance Use Disorders||Behavioral: Risk Reduction through Family Therapy Behavioral: Treatment as Usual||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||135 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Official Title:||Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD|
|Study Start Date :||November 2012|
|Estimated Primary Completion Date :||January 2018|
|Estimated Study Completion Date :||January 2018|
Placebo Comparator: Treatment as Usual (TAU)
Treatment as Usual (TAU) will be defined as it already exists within the community child advocacy centers. This could include individual and/or group therapy using a variety of treatment models.
Behavioral: Treatment as Usual
Participants assigned to the TAU condition will receive the standard treatment that a CSA victim would typically receive at community advocacy centers. In addition to treatment that is typically offered at the CACs, this will include a referral for substance abuse evaluation and may include referrals to other agencies in the community. TAU has been utilized as a comparison condition for several behavioral treatment evaluations involving adolescent substance abuse.
Other Name: TAU
RRFT is an acronym for an experimental intervention named Risk Reduction through Family Therapy. Please see intervention description for more detail about the model.
Behavioral: Risk Reduction through Family Therapy
RRFT is an integrative, ecologically-based approach to risk reduction and treatment. A Stage 1a feasibility trial and a Stage 1b pilot randomized controlled trial (RCT) evaluating RRFT have been completed. This Stage 1 work has resulted in a treatment manual, a clinician training protocol, and a quality assurance system. Preliminary findings from these studies are promising, indicating that RRFT can be readily learned and implemented with fidelity, and that it can lead to improvements in drug use and drug use-related risk and protective factors, PTSD symptoms, and risky sexual behaviors.
Other Name: RRFT
- change in substance use problems (initiation/continuation, quantity, and abuse symptoms) [ Time Frame: 18 months ]
- change in PTSD severity and symptoms [ Time Frame: 18 months ]
- change in risky sexual behaviors [ Time Frame: 18 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01751035
|United States, South Carolina|
|Medical University of South Carolina|
|Charleston, South Carolina, United States, 29425|
|Principal Investigator:||Carla K Danielson, PhD||Medical University of South Carolina|